EcoDrugPlus

Ensembl ID : ENSOTSG00005014214
Gene Symbol: -
Cross references: -
199 Possible Orthologues:

Ensembl ID : ENSOTSG00005045615
Gene Symbol: -
Cross references: -
205 Possible Orthologues:

Ensembl ID : ENSOTSG00005014213
Gene Symbol: -
Cross references: -
159 Possible Orthologues:

Ensembl ID : ENSOTSG00005025843
Gene Symbol: -
Cross references: -
87 Possible Orthologues:

Ensembl ID : ENSOTSG00005026625
Gene Symbol: PSENEN
1 Cross references
176 Possible Orthologues:

Ensembl ID : ENSOTSG00005026500
Gene Symbol: -
Cross references: -
184 Possible Orthologues:

Ensembl ID : ENSOTSG00005042828
Gene Symbol: -
Cross references: -
56 Possible Orthologues:

Ensembl ID : ENSOTSG00005004814
Gene Symbol: -
Cross references: -
194 Possible Orthologues:

Ensembl ID : ENSOTSG00005011649
Gene Symbol: -
Cross references: -
193 Possible Orthologues:

Ensembl ID : ENSOTSG00005014934
Gene Symbol: -
Cross references: -
150 Possible Orthologues:

Ensembl ID : ENSOTSG00005019342
Gene Symbol: -
Cross references: -
505 Possible Orthologues:

Ensembl ID : ENSOTSG00005008741
Gene Symbol: -
Cross references: -
198 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).